AEVASI (Spain) AIVA Italy APACS (Italy) Association Takayasu France ATAK (Takayasu Spain) ELEANA (Greece) France Vascularites Kosapo (Japan) SHG Mainz (Germany) SHG Frankfurt (Germany) SHG Nordbayern (Germany) SHG Sachsen (Germany) VASAS (Switzerland) Vasculitis Awareness Ireland Vasculitis Foundation (USA) Vasculitis Foundation (Canada) Vasculitis (Poland) Vasculitis Society (India) Vasculitis Stichting (Netherlands) Vasculitis UK (United Kingdom) Vaskuliittiyhdistys (Finland) Vaskulitida.cz (Czech Republik)
The latest news......
NEJM Retracts avacopan article
1 July, 2026
Last week added another significant step to the avacopan story: on 29 June 2026, the New England Journal of Medicine retracted the original 2021 ADVOCATE article on Tavneos.
CSL Vifor commitment to the AAV community
26 June, 2026
CSL Vifor Reaffirms Its Commitment to the Vasculitis Community Amid difficult news, a partner that stays present. On the same day that the EMA published
Tavneos update 26 June 2026
26 June, 2026
News | 26 June 2026 EMA Recommends Withdrawal of Tavneos (Avacopan) from the European Market The European Medicines Agency (EMA) has recommended that the marketing
patients
Find Patient Advocacy Groups (VPAGs)
hospitals
Find vasculitis expertise
projects
Find out about the projects we are working on.